Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and

Bharti Vyas1, Sunil Kumar2, Ratul Bhowmik3

  • 1School of Interdisciplinary Science and Technology, Jamia Hamdard, New Delhi, India.

Scientific Reports
|August 22, 2023
PubMed

Insights

Researchers identified three novel key regulators in breast cancer (BC) by analyzing gene expression data and constructing a BC interactome network. These regulators are crucial for understanding BC biomarkers and developing multi-target drugs.

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Biology

Background:

  • Identifying key regulators is crucial for discovering breast cancer (BC) biomarkers.
  • Understanding gene networks can reveal novel therapeutic targets.
  • Multi-target drugs show promise for BC treatment due to higher efficacy and improved safety.

Purpose of the Study:

  • To identify novel key regulators in breast cancer using gene expression data.
  • To construct a breast cancer interactome network to understand regulatory mechanisms.
  • To explore the potential of identified regulators as targets for multi-target drug development.

Main Methods:

  • Utilized a gene expression dataset from breast cancer patients.
  • Employed BioXpress to identify overexpressed genes.
  • Constructed a breast cancer interactome network and analyzed gene degrees to find key regulators.

Main Results:

  • Identified three novel key regulators central to the breast cancer network.
  • These regulators were involved at all network levels, forming the network's backbone.
  • Found evidence linking these genes to breast cancer in existing literature.

Conclusions:

  • The identified key regulators are critical for breast cancer progression and hold potential as biomarkers.
  • These novel regulators could serve as targets for developing effective multi-target drugs for breast cancer.
  • Further research into FN1 gene variations (rs6707530, rs1250248) may aid in predicting drug pharmacokinetics and pharmacodynamics.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K